<I'm guessing this puts another question mark on the "Pfizer will buy YMI" theory.>
So DNDN may still be in the running as a possibility for a Pfizer partnership or acquisition this year? Seems like a reasonable hypothesis from David M's earlier article.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.